GO:0005832 chaperonin-containing T-complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005832 (chaperonin-containing T-complex, also called CCT or TriC) is a multisubunit ring-shaped cytosolic chaperonin that mediates protein folding without a cofactor.
• CCT is built from eight distinct paralogous subunits (TCP1/CCT1 through CCT8) arranged in two stacked rings, forming a barrel-like folding chamber.
• Its best-known substrates are actin and tubulin, but proteomic studies have identified many additional clients in plants, animals and protists.
• CCT function is linked to cancer, neurodegeneration and ciliopathies, making its subunits candidate therapeutic and biomarker targets.
• CCT subunits are studied with CRISPR knockout, point-mutation, knock-in and overexpression models, combined with proteomics and imaging.
• The term is a cellular_component term, so it describes a location and machine rather than an enzymatic activity.
Description
The chaperonin-containing T-complex (GO:0005832), widely known as CCT or TriC, is a large multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor. It was originally identified through the mouse t-complex and has since become a paradigm for ATP-dependent chaperonin-assisted folding in eukaryotes. Unlike the bacterial GroEL/GroES system, CCT is built from eight distinct subunit types and uses its own hetero-oligomeric architecture to recognize a broad set of client proteins. Researchers care about GO:0005832 because it sits at the intersection of proteostasis, cytoskeletal biology and disease. Its canonical clients, actin and tubulin, depend on CCT for proper folding and assembly, and disruption of the complex produces severe cytoskeletal and growth defects. Beyond the cytoskeleton, CCT has been implicated in RNA trafficking, ribonucleoprotein complex formation and signaling regulation in plants and animals. In human health, CCT subunits are increasingly linked to tumor progression, neurodegeneration and other proteostasis-related disorders, which has driven interest in CCT as a drug target and biomarker. This article summarizes the QuickGO definition, the structural and mechanistic features of the complex, the genes involved, disease connections and the experimental methods used to study it.
chaperonin-containing T-complex At A Glance
| GO ID | GO:0005832 |
|---|---|
| GO term | chaperonin-containing T-complex |
| Ontology | cellular_component |
| Synonym | CCT particle; TriC |
| Definition | A multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor |
| Major function | ATP-dependent folding of cytosolic client proteins, including actin and tubulin |
| Subunit composition | Eight distinct subunits (TCP1/CCT1-CCT8) arranged in two stacked rings |
| Cellular location | Cytosol |
| Representative clients | Actin, tubulin and additional proteins identified by proteomics |
What Is GO:0005832?
GO:0005832 describes a multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor. In practice, this means a barrel-like chaperonin machine in which two stacked rings of eight subunits each create a central cavity where client polypeptides can fold in an ATP-dependent manner. The term is a cellular_component term, so it defines where the machine is and what it is made of rather than a catalytic activity on its own.
Why Is chaperonin-containing T-complex Important in Cell Biology?
GO:0005832 is important because the chaperonin-containing T-complex is a central node of cytosolic proteostasis and a determinant of cytoskeletal integrity. Its subunits are required for the folding of actin and tubulin, and loss of CCT function produces severe defects in cell growth, division and morphology. In addition, CCT has been linked to cancer progression, neurodegeneration and other diseases, making it a promising target for mechanistic and translational studies.
• CCT is required for folding of actin and tubulin, two of the most abundant cytoskeletal proteins.
• It is a major cytosolic chaperonin and a key component of the proteostasis network.
• CCT subunits are overexpressed or dysregulated in several cancers, including non-small cell lung cancer.
• The complex participates in ribonucleoprotein complex formation and long-distance RNA trafficking in plants.
• CCT dysfunction is associated with neurodegeneration and other protein-folding disorders.
• Its hetero-oligomeric structure makes it a useful model for studying allostery and substrate recognition.
• CCT subunits can serve as biomarkers and potential therapeutic targets.
• Comparative studies in plants, protists and animals reveal conserved and species-specific clients.
• CRISPR models of CCT subunits enable causal testing of its roles in growth and disease.
• The complex is a paradigm for understanding cofactor-independent chaperonin mechanisms.
What Happens During chaperonin-containing T-complex?
Substrate capture and recognition
In simple terms: CCT grabs partly folded proteins and holds them so they can fold correctly.
The chaperonin-containing T-complex recognizes hydrophobic and other exposed surfaces on client proteins such as actin and tubulin, capturing them before they aggregate. Substrate recognition is mediated by the apical domains of the eight subunits, which together create a versatile binding surface for diverse clients. Proteomic studies have expanded the known client list beyond actin and tubulin, showing that CCT interacts with many cytosolic proteins.
ATP-dependent folding cycle
In simple terms: CCT uses energy from ATP to close around its client and help it fold.
Binding of ATP to the equatorial domains of CCT induces conformational changes that drive the folding cycle. The complex can adopt multiple nucleotide states, and these states are coupled to client release and folding. Unlike bacterial chaperonins, CCT does not require a cofactor such as GroES, and its lid is formed by the same ring subunits.
Client release and functional maturation
In simple terms: Once the protein is folded, CCT releases it so it can do its job.
After one or more rounds of ATP hydrolysis, the folded client is released from the CCT cavity. For actin and tubulin, release is coupled to assembly into filaments and microtubules, respectively. In plants, CCT has also been implicated in the formation of ribonucleoprotein complexes required for long-distance RNA trafficking.
Integration with the cytosolic proteostasis network
In simple terms: CCT works alongside other chaperones to keep the cell's proteins healthy.
CCT functions within a broader cytosolic chaperone network that includes Hsp70 and Hsp90 systems. Its activity is coordinated with co-chaperones and folding factors to maintain proteostasis under normal and stress conditions. Dysregulation of this network can shift CCT clients toward aggregation or degradation.
Key Genes Involved in GO:0005832 chaperonin-containing T-complex
The chaperonin-containing T-complex is encoded by eight paralogous subunit genes, each contributing a distinct ring position and client-binding surface.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TCP1 (CCT1) | Alpha subunit of the CCT ring; contributes to substrate binding and ATP hydrolysis | Core subunit; knockout is expected to disrupt actin and tubulin folding |
| CCT2 | Beta subunit; part of the apical substrate-binding domain | Studied in cancer and proteostasis models |
| CCT3 | Gamma subunit; implicated in tumor growth and YAP1 signaling | Knockdown reduces non-small cell lung cancer growth |
| CCT4 | Delta subunit; contributes to ring assembly and client recognition | Candidate for structural and interaction studies |
| CCT5 | Epsilon subunit; linked to sensory neuropathy in humans | Disease-relevant subunit for neurodegeneration models |
| CCT6A | Zeta subunit; participates in substrate binding | Potential biomarker in cancer |
| CCT7 | Eta subunit; required for folding of actin and tubulin | Used in proteomics and interactome studies |
| CCT8 | Theta subunit; completes the hetero-oligomeric ring | Target for knockout and assembly studies |
| ACTB | Major CCT client; actin folding and assembly | Readout for CCT function in cytoskeleton assays |
| TUBA1A | Major CCT client; tubulin folding | Readout for CCT function in microtubule assays |
| TUBB | Major CCT client; tubulin folding | Readout for CCT function in microtubule assays |
| YAP1 | Downstream effector affected by CCT3 loss | Used to link CCT3 to Hippo signaling in cancer |
| PbWoxT1 | Plant RNA-binding protein whose ribonucleoprotein complex requires CCT | Model for RNA trafficking studies in plants |
| PbPTB3 | Plant RNA-binding protein partner in CCT-dependent complex | Model for RNA trafficking studies in plants |
| HSPA1A | Cytosolic Hsp70 that cooperates with CCT in proteostasis | Used in chaperone network studies |
| HSP90AA1 | Cytosolic Hsp90 that cooperates with CCT in proteostasis | Used in chaperone network studies |
| STIP1 | Co-chaperone that coordinates Hsp70 and Hsp90 | Used in chaperone network studies |
How Is chaperonin-containing T-complex Regulated?
CCT activity is regulated at multiple levels, including subunit gene expression, ATP binding and hydrolysis, and interactions with co-chaperones. The complex cycles through nucleotide-dependent conformational states that control client binding and release. In cancer cells, CCT subunit expression can be altered by oncogenic signaling, and CCT3 loss affects YAP1-related pathways. In plants, CCT-dependent ribonucleoprotein complex formation is linked to developmental and RNA-trafficking cues.
chaperonin-containing T-complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCT3 | Non-small cell lung cancer; YAP1 signaling | Knockout or knockdown in lung cancer cell lines |
| CCT5 | Sensory neuropathy; proteostasis | Point-mutation knock-in in neuronal cells |
| TCP1 | Cytoskeletal folding defects | Knockout in model cell lines with actin/tubulin readouts |
| CCT2 | Cancer and proteostasis | Overexpression and knockout in cancer lines |
| CCT8 | Ring assembly and growth | Tagged knock-in for imaging assembly |
Cancer
CCT subunits are frequently dysregulated in cancer, and CCT3 restraint has antitumor roles in non-small cell lung cancer through effects on YAP1. The complex supports the folding of cytoskeletal and signaling proteins that cancer cells need for proliferation and migration. These findings make CCT subunits candidate biomarkers and therapeutic targets.
Neurodegeneration
CCT dysfunction has been linked to neurodegenerative conditions in which proteostasis is impaired. Because CCT is required for folding of cytoskeletal proteins, its failure can compromise neuronal structure and transport. Mutations in CCT subunits have been associated with sensory neuropathy, highlighting its importance in neurons.
Ciliopathies and developmental disorders
CCT clients include proteins required for cilia and cytoskeletal organization, and defects in these processes can contribute to ciliopathy-related phenotypes. Bardet-Biedl syndrome is a ciliopathy with multisystem features, and chaperone-related pathways may modify its presentation. However, direct CCT mutations in ciliopathies remain an area of active investigation.
From chaperonin-containing T-complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a CCT subunit required for cell growth? | CRISPR knockout in a diploid cell line |
| Does a patient variant impair CCT function? | Point-mutation knock-in of the variant |
| Where does CCT localize in live cells? | Tagged knock-in with a fluorescent protein |
| Does CCT overexpression drive transformation? | Overexpression in cancer cell lines |
| Which proteins depend on CCT for folding? | Knockout plus proteomics |
| Does CCT3 loss affect YAP1 signaling? | Knockdown or knockout with YAP1 readouts |
How to Study the chaperonin-containing T-complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Affinity purification-mass spectrometry | CCT interactors and clients | Mapping the CCT interactome |
| Fluorescence microscopy | Subcellular localization and assembly | Live-cell imaging of tagged CCT |
| Cytoskeletal assays | Actin and tubulin folding/assembly | Functional readout of CCT loss |
| CRISPR knockout | Requirement for a CCT subunit | Causal testing in cell lines |
| RNA-seq | Transcriptional changes after CCT perturbation | Pathway analysis in cancer models |
| Proteomics | Global protein abundance and folding status | Proteostasis profiling |
| Co-immunoprecipitation | Physical interactions among CCT subunits | Assembly and complex integrity |
| Structural analysis | Ring architecture and conformational states | Mechanistic studies of the folding cycle |
Proteomics and interactomics
Affinity purification and mass spectrometry can identify CCT subunits and their client proteins, as shown in studies that expanded the CCT substrate list. These approaches reveal dynamic interactions and help distinguish direct clients from bystanders.
Imaging and localization
Fluorescence microscopy of tagged CCT subunits allows visualization of the complex in the cytosol and its association with cytoskeletal structures. Live-cell imaging can track ring assembly and client release.
Functional assays for actin and tubulin
Because actin and tubulin are canonical CCT clients, cytoskeletal assays are standard readouts for CCT function. These include filament formation, microtubule regrowth and cell morphology analyses.
Genetic and CRISPR screens
CRISPR knockout and knockdown screens can test the requirement for each CCT subunit in growth, stress survival and disease phenotypes. Such screens help link specific subunits to distinct client networks.
How CRISPR Can Be Used to Study GO:0005832 chaperonin-containing T-complex
Knockout
CRISPR knockout of individual CCT subunits can reveal which functions require the intact chaperonin-containing T-complex. For example, CCT3 restraint has antitumor roles in non-small cell lung cancer, and knockout or knockdown can test this effect. Knockout models are also useful for identifying essential subunits and client dependencies.
Point Mutation
Point-mutation knock-in can model patient variants or disrupt ATP binding and subunit interfaces. Such models help distinguish loss-of-function from dominant-negative effects. They are particularly useful for studying CCT5-related neuropathy variants.
Knock-in
Tagged knock-in of CCT subunits enables imaging and interaction studies without overexpression artifacts. Fluorescent or affinity tags can be introduced at endogenous loci to track assembly and localization. This approach supports live-cell analysis of the chaperonin cycle.
Overexpression
Overexpression of CCT subunits can test whether increased chaperonin capacity promotes growth or transformation. It is also used to rescue knockout phenotypes and to study subunit stoichiometry. Overexpression models complement loss-of-function studies in cancer and proteostasis research.
How EDITGENE Supports chaperonin-containing T-complex Research
Researchers studying chaperonin-containing T-complex-related genes often need to determine whether a candidate gene is causally involved in folding, growth or disease, and CRISPR-based models provide a direct way to test this. EDITGENE supports these studies with knockout, point-mutation, knock-in, overexpression and screening services tailored to CCT subunits and their clients.
Contact EDITGENE today to design your custom CRISPR model for chaperonin-containing T-complex research.
Frequently Asked Questions About chaperonin-containing T-complex
What is GO:0005832?
GO:0005832 is the Gene Ontology cellular_component term for the chaperonin-containing T-complex, a multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor.
What is the chaperonin-containing T-complex also called?
It is also known as CCT or TriC.
What genes are involved in the chaperonin-containing T-complex?
The complex is encoded by eight subunit genes, including TCP1 (CCT1), CCT2, CCT3, CCT4, CCT5, CCT6A, CCT7 and CCT8.
What proteins does CCT fold?
CCT folds actin and tubulin, and proteomic studies have identified additional client proteins in animals, plants and protists.
Is CCT involved in cancer?
Yes, CCT subunits are dysregulated in several cancers, and CCT3 restraint has antitumor roles in non-small cell lung cancer via YAP1.
How is CCT studied experimentally?
Common methods include affinity purification-mass spectrometry, fluorescence imaging, cytoskeletal assays and CRISPR knockout.
Does CCT require a cofactor?
No, the chaperonin-containing T-complex mediates protein folding in the cytosol without a cofactor.
What is the structure of CCT?
CCT is a ring-shaped complex composed of eight distinct subunits arranged in two stacked rings.
Is CCT linked to neurodegeneration?
CCT dysfunction has been linked to neurodegenerative conditions and sensory neuropathy.
Can CRISPR be used to study CCT?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models are widely used to study CCT subunit function.
Conclusion
GO:0005832 describes the chaperonin-containing T-complex, a cytosolic ring-shaped machine that folds key proteins such as actin and tubulin without a cofactor. Its eight subunits, broad client network and links to cancer and neurodegeneration make it a rich subject for mechanistic and translational research. CRISPR-based models and proteomic methods now allow precise testing of CCT subunit function in health and disease.
References
- 1. Adam MP et al.. 1993. Bardet-Biedl Syndrome Overview.. PMID: 20301537
- 2. Kubota H et al.. 1995. The chaperonin containing t-complex polypeptide 1 (TCP-1). Multisubunit machinery assisting in protein folding and assembly in the eukaryotic cytosol.. Eur J Biochem 230(1):3-16 PMID: 7601114
- 3. Anand A et al.. 2024. Epsilon subunit of T-complex protein-1 from Leishmania donovani: A tetrameric chaperonin.. Gene 926:148637 PMID: 38844270
- 4. Wang S et al.. 2023. A chaperonin containing T-complex polypeptide-1 facilitates the formation of the PbWoxT1-PbPTB3 ribonucleoprotein complex for long-distance RNA trafficking in Pyrus betulaefolia.. New Phytol 238(3):1115-1128 PMID: 36751904
- 5. Zeng C et al.. 2024. Revisiting the chaperonin T-complex protein-1 ring complex in human health and disease: A proteostasis modulator and beyond.. Clin Transl Med 14(2):e1592 PMID: 38363102
- 6. Shi H et al.. 2022. Restraint of chaperonin containing T-complex protein-1 subunit 3 has antitumor roles in non-small cell lung cancer via affection of YAP1.. Toxicol Appl Pharmacol 439:115926 PMID: 35182550
- 7. Ahn HK et al.. 2019. Functional characterization of chaperonin containing T-complex polypeptide-1 and its conserved and novel substrates in Arabidopsis.. J Exp Bot 70(10):2741-2757 PMID: 30825377
- 8. Horovitz A et al.. 2022. Chaperonin Mechanisms: Multiple and (Mis)Understood?. Annu Rev Biophys 51:115-133 PMID: 34982571
